[go: up one dir, main page]

ATA5872004A - Verwendung von capsaicin und/oder capsaicinoiden - Google Patents

Verwendung von capsaicin und/oder capsaicinoiden

Info

Publication number
ATA5872004A
ATA5872004A AT0058704A AT5872004A ATA5872004A AT A5872004 A ATA5872004 A AT A5872004A AT 0058704 A AT0058704 A AT 0058704A AT 5872004 A AT5872004 A AT 5872004A AT A5872004 A ATA5872004 A AT A5872004A
Authority
AT
Austria
Prior art keywords
capsaicinoides
capsaicin
Prior art date
Application number
AT0058704A
Other languages
English (en)
Other versions
AT413646B (de
Original Assignee
Hammer Johann Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hammer Johann Dr filed Critical Hammer Johann Dr
Priority to AT0058704A priority Critical patent/AT413646B/de
Priority to EP05714194A priority patent/EP1734943A1/de
Priority to PCT/AT2005/000113 priority patent/WO2005094807A1/de
Publication of ATA5872004A publication Critical patent/ATA5872004A/de
Application granted granted Critical
Publication of AT413646B publication Critical patent/AT413646B/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0058704A 2004-04-02 2004-04-02 Verwendung von capsaicin und/oder capsaicinoiden Expired - Fee Related AT413646B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT0058704A AT413646B (de) 2004-04-02 2004-04-02 Verwendung von capsaicin und/oder capsaicinoiden
EP05714194A EP1734943A1 (de) 2004-04-02 2005-03-31 Verwendung von capsaicin und capsaicinoiden zur diagnose chemischer hypersensibilität
PCT/AT2005/000113 WO2005094807A1 (de) 2004-04-02 2005-03-31 Verwendung von capsaicin und capsaicinoiden zur diagnose chemischer hypersensibilität

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0058704A AT413646B (de) 2004-04-02 2004-04-02 Verwendung von capsaicin und/oder capsaicinoiden

Publications (2)

Publication Number Publication Date
ATA5872004A true ATA5872004A (de) 2005-09-15
AT413646B AT413646B (de) 2006-04-15

Family

ID=34916804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0058704A Expired - Fee Related AT413646B (de) 2004-04-02 2004-04-02 Verwendung von capsaicin und/oder capsaicinoiden

Country Status (3)

Country Link
EP (1) EP1734943A1 (de)
AT (1) AT413646B (de)
WO (1) WO2005094807A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
US20240099998A1 (en) * 2021-01-15 2024-03-28 Dignify Therapeutics, Llc Compositions and methods for inducing defecation
CN113143899A (zh) * 2021-05-13 2021-07-23 中国人民解放军陆军军医大学第二附属医院 辣椒素在制备治疗溃疡性结肠炎药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5431914A (en) * 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
AU5460598A (en) * 1996-11-15 1998-06-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
SE523550C2 (sv) * 1999-07-08 2004-04-27 Eva Millqvist Användning av capsaicin
WO2003015698A2 (en) * 2001-08-13 2003-02-27 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
FR2849992B1 (fr) * 2003-01-17 2007-03-16 Inst Phytoceutic Composition pour une administration par voie orale contenant des capsaicinoides

Also Published As

Publication number Publication date
AT413646B (de) 2006-04-15
EP1734943A1 (de) 2006-12-27
WO2005094807A1 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
ATE539064T1 (de) Heterozyklische inhibitoren von mek und verwendungsverfahren damit
EP1746902A4 (de) Multilektin-affiniätschromatografie und verwendung dafür
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
EP1955844A4 (de) Verbundfolie und verwendung davon
EP1796155A4 (de) Beulenbildungsverfahren und lotbeule
ATE391718T1 (de) Phenylacetamide und ihre verwendung als glukokinase-modulatoren
DE602006018166D1 (de) Polyrotaxanhaltige lösung und verwendung davon
EP1824544A4 (de) Atmungsvorrichtungen und verfahren zur verwendung
DE502005006470D1 (de) Verwendung von sulfonylharnstoffen
DE602005012267D1 (de) N von geräten
DE602006007970D1 (de) Hydroxydesoxybenzoine und ihre verwendung zur maskierung von bittergeschmack
EP1954140A4 (de) Glycerinlevulinatketale und ihre verwendung
ATE524183T1 (de) Verwendung von sanglifehrin bei der hcv-therapie
DE602005017635D1 (de) Harzzusammensetzung und formteil daraus
ATE428710T1 (de) Substituierte phenylaminothiazole und ihre verwendung
EP1499186A4 (de) Verwendung von häm-oxygenase-1 und häm-abbauprodukte
EP1945819A4 (de) Genexpressionsprofile und anwendungsverfahren
DE602006009296D1 (de) Oligopeptide und ihre verwendung
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
ATE493396T1 (de) Neue indazolcarboxamide und ihre verwendung
DE602006019849D1 (de) Proteinspaltungsverfahren und verwendung davon
DE112005000151A5 (de) Verwendung von Kern-Mantel-Partikeln
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
ATE523594T1 (de) Modifizierung von pflanzenentwicklung und - morphologie

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee